Industry Insights Logo

Medicaid Drug Rebate Program Summit – MDRP 2024

SPONSORED CONTENT

Experts from across the US come together each year to conquer the complex, ever-evolving Medicaid drug rebate and 340B programs and accelerate their careers by sourcing world-class content alongside everyone who matters in Medicaid. Join us in Chicago on September 23-25 for the 2024 Medicaid Drug Rebate Program Summit where you’ll benefit from three days of learning, education and networking, and will return to the office having mastered regulatory guidelines to deliver compliant government pricing and reporting programs. 

More than 100 world class speakers are slated to present deep dive sessions, workshops and panels covering these topics and more:

  • Featured Workshops and Sessions – 340B Compliance Cornerstones for Manufacturers, 340B Boot Camp with Education for Manufacturers, Operationalizing 340B Policy, Reform and Program Updates.
  • Two Sessions from HRSA – Key Updates from HRSA’s Office of Pharmacy Affairs on the 340B Program and HRSA 340B Program Manufacturer Audit Process.
  • State of the Industry Panel – Covington & Burling, Healthcare Leadership Council, NORD, PhRMA and Horizon Government Affairs discuss modeling potential outcomes post-election.
  • State Dispute Resolution Meetings – Manufacturers and States come together to discuss issues or questions related to rebates, reporting and more. Confirmed states include: Alaska • Arizona • Arkansas • California • Colorado • Connecticut • Delaware • District of Columbia • Georgia • Hawaii • Idaho • Illinois • Indiana • Louisiana • Maryland • Massachusetts • Michigan • Montana • Nebraska • New Hampshire • New Mexico • New York • Nevada • North Carolina • Pennsylvania • Rhode Island • South Carolina • Tennessee • Virginia • Wisconsin.
  • Best Practices and Policy Ideas Town Hall – Listen in on an open dialogue covering processing claims, bid cycles, P&T meetings, reimbursement and more, led by Gainwell Technologies, Gilead Sciences, IL HFS Medicaid Drug Rebate Unit, AstraZeneca, and Conduent.
  • Ask the Attorneys Panel – Join this open Q&A with external counsel from Sidley Austin LLP and Latham & Watkins to get answers to your most challenging questions.
  • OIG Address – The Office of the Inspector General reviews recent OIG evaluations involving prescription drug pricing, payment and coverage.
  • Workshops and Tracks throughout the Summit Covering GP 101, GTN Best Practices, Practical Strategies for Emerging, Small, and Mid-Sized Companies, State Drug Price Transparency, 340B, IRA, Tech and AI, State Level Trends, GP Recalculations across Government Programs, Smoothing Program Updates, and PDAB and SPTR Best Practices.
  • Back by Popular Demand – Closed Door Executive Strategy Summit!
  • And much more!

View the agenda for the MDRP Summit to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/MDRPSummit for further details and to register. 340B Report readers will save 10% off when they use code 24BRPT10.*

Website | + posts